HDAC9 and neoplasm: HDAC inhibitors, such as suberoylanilide hydroxamic acid (SAHA) and trichostatin A (TSA), have been shown to induce apoptosis in neoplastic cells in vitro and inhibit tumor growth in vivo in animal models [28-31].